Inflexion Point

When an entrepreneur sells their business, the next question is what to do with the proceeds. Marktlink Capital was built to answer it. Founded in 2020, it has raised over €3bn in committed capital, almost entirely from Dutch entrepreneurs and families, and Inflexion has made a minority investment to back its ambition to become Europe’s leading private markets platform. 🤝

In this episode, Marktlink Group managing partners Tim van der Meer and Tom Beltman join Inflexion’s Sander Ruijter and host Tim Smallbone to share why they chose a minority partner when they had no wish to sell, how a commercial culture built in M&A advice became an edge in private markets, and why asset managers need to be hunters as well as farmers.

Most pharma businesses are built on new drugs. CNX Therapeutics was built on the ones big pharma had overlooked. Carved out of US group Sunovion in 2021 with a single product, it now spans more than 60 countries, has grown to 25 products, and become the first UK pharmaceutical company to earn B Corp status. 💊

In this episode, CNX CEO Guy Clark joins host Tim Smallbone and Inflexion's Christian Fellowes to explore how a thesis first sketched on a napkin became a pan European platform, why so many effective medicines never reach the patients who need them, and how you scale from 17 people to nearly 70 without losing your culture.

Artificial intelligence will decide which businesses thrive over the next decade and which get left behind. But the biggest barrier is not the technology. It is people, culture, and leaders who have not yet seen what it can really do. 🤖

In this episode, Greg Nieuwenhuys, chair of Inflexion portfolio company Nodor and senior partner at AI advisory firm WAIMAKERS, joins Inflexion's Alex Mathers and host Tim Smallbone to explore what it takes to make AI stick in a business: why adoption has to be owned by the CEO, why the prize is reimagining your value proposition rather than cutting costs, and why human skills matter more than ever. 🧠

In 1999, three students at the University of Karlsruhe built a free stock market platform because they couldn't afford the data they needed to invest. Twenty-five years later, Finanzen.net is Germany's number one financial media and investing platform, with 6 million monthly users, a free neobroker, and an ambitious vision to become the leading investment and savings platform across the DACH region. 📈

In this episode, co-founder Jens Ohr joins Inflexion Partner and Head of Financial Services Andrea Bertolini and host Tim Smallbone to tell that story, including the 2025 carve-out from Axel Springer that gave the business its independence. They explore why only one in five Germans invests in the stock market and how that is changing fast, what made Finanzen.net stand out to Inflexion, and how you find the right partner for a business you've spent 25 years building. Jens and Andrea also share why the ambition from here is to become the home for every investor across the DACH region.

✅🔍📋 Having led three testing, inspection and certification businesses and watched an enormous, fragmented market grow around him, Simon Parrington saw an opportunity: not to buy an existing platform, but to build the ideal long-term home for founder-led businesses from scratch.

In this episode, Simon joins Inflexion Investment Director Dominic Clark and host Tim Smallbone to tell the story of Celnor - the buy and build platform created with Inflexion in 2023 that has completed 42 acquisitions in just over two years. They explore why the compliance market remains so fragmented, how Celnor wins over 70% of its deals off-market, and how the group is providing a more holistic set of services for customers . Simon also shares how Celnor delivered its original five-year plan in under three years - and why the goal from here is over £1 billion in revenues by 2031. 🏗️